Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

China flag China · Delayed Price · Currency is CNY
14.89
-0.05 (-0.33%)
At close: Feb 27, 2026
Market Cap6.22B +21.4%
Revenue (ttm)786.51M -0.5%
Net Income74.61M +19.4%
EPS0.18 +19.3%
Shares Out417.60M
PE Ratio83.37
Forward PEn/a
Dividend0.10 (0.67%)
Ex-Dividend DateSep 9, 2025
Volume1,232,842
Average Volume2,797,939
Open14.93
Previous Close14.94
Day's Range14.79 - 14.93
52-Week Range11.42 - 22.69
Beta-0.18
RSI45.66
Earnings DateApr 24, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1996
Employees 1,384
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002907
Full Company Profile

Financial Performance

In 2024, SHE:002907's revenue was 774.82 million, an increase of 12.04% compared to the previous year's 691.54 million. Earnings were 76.73 million, an increase of 134.66%.

Financial Statements